Renadyl and Kibow Fortis: A Synbiotic Combination

Kibow Biotech sells two separate products (Renadyl & Kibow Fortis) that when paired together can work hand in hand toRenadyl-bottle-front maximize efficiency, this combination is known as a synbiotic.

What is a synbiotic?

Synbiotic formulas are synergistic by nature and promote the growth of essential beneficial probiotics within your colon. Renadyl is an elite formulation of patented, proprietary strains of probiotic microorganisms which may help maintain healthy kidney function. Without Kibow Fortis (our prebiotic product) Renadyl has been shown to maintain healthy kidney function in clinical trials. However, pairing Renadyl with Kibow Fortis may aid in supporting healthy kidney function via its lactogenic (ability to promote the growth of lactobacilli), and bifidogenic (ability to promote the growth of bifidobacterium) properties. Even if you aren’t taking Renadyl, many of the probiotic supplements on the market today feature beneficial microorganisms of the lactobacilli and bifidobacterium order.

What about Kibow Fortis Synbiotic - Renadly & Kibow Fortisgives it its lactogenic/bifidogenic properties?

Kibo-Fortis-bottle-front1It’s all in the formula! Two of the fibers featured in Kibow Fortis have been scientifically proven to promote the growth of these two orders of beneficial microorganisms. These two fibers are xylooligosaccharide, and arabinogalactan, two extensively studied prebiotic fibers.

The secret to the prebiotic abilities of these two fibers is all in the SCFA or Short Chain Fatty Acids that they are fermented into. The probiotic bacteria in the colon are able to utilize the fiber products and metabolize them, the byproduct of this metabolization are the SCFAs. SCFAs are then utilized by the human body to: enhance blood flow, lower colonic pH, provide energy for colonocytes (colonic membrane cells), inhibit cholesterol synthesis, regulate the immune system, and may reduce the risk of colorectal cancer.

These lactogenic and bifidogenic properties are only a part of what makes Kibow Fortis the premier complete fiber supplement. The fibers that make up Kibow Fortis may be able to assist in managing cholesterol, weight, sense of fullness, regulate the immune system, and could reduce the risk of colorectal cancer. Even if you do not take Renadyl or any probiotic supplement for that matter, Kibow Fortis has something to offer.

Safety Assessment of Probiotics for Human Use

Are Probiotics Safe?

  1. Please refer to the article written by Sanders et al. in the esteemed journal Gut Microbes.* As will be evident from reviewing this recent article, all probiotic strains manufactured by well-established firms with stringent c-GMP conditions either for food or dietary supplement use are assured of its safety.  US FDA, recognizes these probiotic strains as “Generally Recognized As Safe – (GRAS)” status. There exists no commercial scale manufacturing facility to produce any probiotic strains with a Drug Master File (DMF).  Hence, there are currently no probiotic products classified as a drugs.Safety Assessment of Probiotics
  1. Our raw materials are sourced from one of the top three probiotic manufacturers in the world, based out of the United States of America. They are US FDA inspected and adhere to controlled Good Manufacturing Production (c-GMP) facility guidelines – with in-house and external verification, certification, and documentations.
  1. Likewise our finished product formulations are manufactured by a US FDA inspected facility in the United States – with in-house and external verification, certification, and documentations.
  1. The final manufactured products are each tested for its quality, viable counts, purity and other needed tests for every lot produced by our manufacturer at Kibow’s R&D labs. We also perform stability studies periodically at 4 degrees Celsius, monthly for three consecutive months and then quarterly for a period of two years (expiration period) for each lot.
  1. Kibow also has two outside contract labs in the United States for fatty acid analysis and for strain verification in our products, and for contamination analysis for any pathogenic or harmful microbial strains.
  1. As of now, there are no complaints reported either directly to us or notified to US FDA on any safety issues by the use of RENADYL™ from any of our customers since April 1, 2010 when we started selling the product – RENADYL™ with our structure function claim “Helps maintain a healthy kidney function”.

Natarajan Ranganathan, Ph.D., – Managing Director (R&D)

*Sanders, Mary Ellen, Lois M.a. Akkermans, Dirk Haller, Cathy Hammerman, James T. Heimbach, Gabriele Hörmannsperger, and Geert Huys. “Safety Assessment of Probiotics for Human Use.” Gut Microbes 1.3 (2010): 164-85.